Daniel S. Kohane
27Patents
6h-index
35Co-inventors
69Inventor score
Filing activity: May 15, 1998 → Jul 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6326020A | Local anesthetic formulations | Human Necessities | 249 | Expired |
| US8414912B2 | Contact lens drug delivery device | Emerging Cross-Sectional Technologies | 28 | Active |
| US9457047B2 | Immunomodulating compositions and methods of use thereof | Chemistry; Metallurgy | 25 | Active |
| US8975268B2 | Neosaxitoxin combination formulations for prolonged local anesthesia | Human Necessities | 13 | Active |
| US8975281B2 | Neosaxitoxin combination formulations for prolonged local anesthesia | Human Necessities | 12 | Active |
| US8912304B2 | Polyol-based polymers | Human Necessities | 6 | Active |
| US10350320B2 | Magnetic separation using nanoparticles | Human Necessities | 6 | Active |
| US9457128B2 | Scaffolds comprising nanoelectronic components for cells, tissues, and other applications | Human Necessities | 3 | Active |
| US10010709B2 | Composition for on-demand ultrasound-triggered drug delivery | Human Necessities | 3 | Active |
| US8822410B2 | Tympanic membrane permeating ear drops and uses thereof | Human Necessities | 3 | Active |
| US9114009B2 | Nanowired three dimensional tissue scaffolds | Emerging Cross-Sectional Technologies | 2 | Active |
| US9186640B2 | Delivery and controlled release of encapsulated lipophilic nutrients | Human Necessities | 2 | Active |
| US10314833B2 | Neosaxitoxin combination formulations for prolonged local anesthesia | Human Necessities | 1 | Active |
| US8658699B2 | Chemical permeation enhancers enhance nerve blockade by toxins | Human Necessities | 1 | Active |
| US11110175B2 | Compositions with permeation enhancers for drug delivery | Chemistry; Metallurgy | 1 | Active |
| US12053527B2 | Compositions with permeation enhancers for drug delivery | Chemistry; Metallurgy | 0 | Active |
| US10881647B2 | Neosaxitoxin combination formulations for prolonged local anesthesia | Human Necessities | 0 | Active |
| US11071714B2 | Poly(ketals) and related compositions and methods | Human Necessities | 0 | Active |
| US9408846B2 | Formulations and methods for delaying onset of chronic neuropathic pain | Human Necessities | 0 | Active |
| US11344498B2 | Compositions and methods for on-demand high-efficiency triggerable anesthesia | Human Necessities | 0 | Active |
| US9168389B2 | Harmonic generation for activation of species and/or delivery of species to a target environment | Human Necessities | 0 | Active |
| US11559586B2 | Nanoparticles for treatment of choroidal neovascularization and other indications | Human Necessities | 0 | Active |
| US8609733B2 | Sensory-specific local anesthesia and prolonged duration local anesthesia | Human Necessities | 0 | Active |
| US10369255B2 | Scaffolds comprising nanoelectronic components for cells, tissues, and other applications | Human Necessities | 0 | Active |
| US12427196B2 | Macromolecular prodrugs for light-emitting diodes and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.